FDA approves gene-editing treatment for sickle cell disease

Image source -

Sickle cell disease affects approximately 100,000 people in the U.S., predominantly people of color.


Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy
We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.

Hot daily news right into your inbox.